Case Report: Complete hydatidiform mole mimicking spondyloarthritis: a probable paraneoplastic rheumatologic syndrome. [PDF]
Gao Z, Zhang Q, Ma Z.
europepmc +1 more source
Lower Limb Nonvisualization Caused by Macroarterial Thrombosis After Cervical Cancer TP Chemotherapy in Whole-body Bone Scintigraphy. [PDF]
Liang C, Li M, Wang H, He T, Cai H.
europepmc +1 more source
Summary of the Asia Pacific Advanced Prostate Cancer Symposium 2025, showing disciplines and diversity of participants, discussion topics (high‐risk localized/locally advanced prostate cancer; PSA persistence and recurrence; radioligand therapy; genetics and genomics; bone protection and other aspects of supportive care), key themes, and high‐level ...
Edmund Chiong +28 more
wiley +1 more source
Association Between Biochemical Parameters, Parathyroid Gland Morphometry, and Dual-Phase MIBI SPECT/CT Findings in Primary Hyperparathyroidism. [PDF]
Krzentowska A +4 more
europepmc +1 more source
Concurrent Hashimoto's Encephalopathy and Papillary Thyroid Carcinoma: A Case Report
ABSTRACT Background Hashimoto's encephalopathy (HE) is a rare steroid‐responsive autoimmune syndrome. Although HE is associated with anti‐thyroid antibodies, its concurrence with malignant thyroid tumors has rarely been described and its clinical implications remain poorly understood.
Ryo Hara +12 more
wiley +1 more source
Is three-phase bone scintigraphy really obsolete? : a combined TPBS-CRP diagnostic method. [PDF]
Chen Q +7 more
europepmc +1 more source
ABSTRACT Objectives Prostate‐specific membrane antigen positron emission tomography (PSMA‐PET) is a sensitive imaging modality for detecting recurrent prostate cancer following definitive local therapy. However, evidence on 18F‐labeled PSMA tracers in Japanese patients with biochemical recurrence (BCR) remains limited.
Koji Hatano +15 more
wiley +1 more source
Parathyroid carcinoma diagnosed after pulmonary metastases 8 years after initial parathyroidectomy. [PDF]
Matsuda N +5 more
europepmc +1 more source
ABSTRACT Background Radium‐223 dichloride (Ra‐223) is an effective treatment for metastatic castration‐resistant prostate cancer (mCRPC) with bone metastases. However, predictive factors associated with treatment efficacy remain unclear. This study evaluated prognostic factors associated with the efficacy of Ra‐223 and investigated outcomes according ...
Kodai Abe +14 more
wiley +1 more source
Radiological Imaging in Gastroparesis: A Narrative Literature Review of Diagnostic and Evaluation Techniques. [PDF]
Raouf MH, Raouf M, Youssef F.
europepmc +1 more source

